SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77502.12
579.48 (0.75%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
121	Kopran Ltd.	Q V PT	903 Small Cap	186.95 (-0.98%)	29.69	2.02	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
122	Sigachi Industries Ltd.	Q V+ PT	879 Small Cap	23 (-1.96%)	N/A	1.85	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
123	Shree Ganesh Remedies Ltd.	Q V PT	825 Small Cap	642.40 (-4.38%)	46.4	5.06	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
124	Anuh Pharma Ltd.	Q V PT	817 Small Cap	81.49 (1.88%)	19.9	2.32	16.60	20.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
125	Fabtech Technologies Ltd.	Q V PT	719 Small Cap	161.75 (2.73%)	29.65	1.84	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
126	Nectar Lifesciences Ltd.	Q V PT	230 Small Cap	11.85 (2.16%)	N/A	0.4	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	298.65	8.92%
Themis Medicare	119.15	7.73%
Dishman Carbogen Amc	188	7%
Shilpa Medicare	600.85	5.26%
GPT Healthcare	156.45	4.40%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
KMC Speciality Hosp.	133.60	-5.01%
Morepen Laboratories	59.71	-4.63%
Fischer Medical	39.08	-4.59%
Shree Ganesh Remed.	642.40	-4.38%
Gufic Biosciences	385.40	-2.24%

News about Top Pharma Companies in India

Jul, 2026

Fabtech Technologies informs about outcome of postal ballot

Fabtech Technologies has informed that the Company had sought consent from members of the Company on the following resolutions through Postal Ballot notice dated May 25, 2026: Appointment of Rupal Dhiren Haria (DIN: 10624643) as a Non-Executive Independent Director of the Company; and Appointment of Bharti Khanna (DIN: 05147844) as a Non-Executive Independent Director of the Company. Based on the report issued by our Scrutinizer, CS Rachana Shanbhag, Partner of DA Kamat & Co., Company Secretaries, (FCS: 8227/ CP: 9297), the above resolutions have been passed and the same are deemed to have been approved on the last date of e-voting period i.e., Tuesday, June 30, 2026. The voting results in the format prescribed under Regulation 44(3) of SEBI. Listing. Regulations, along with the Scrutinizer's Report on remote e-voting, in respect of above resolutions are attached. The Voting Results along with the Scrutinizer's Report are available on the Company's website www.fabtechnologies.com and also on the website of NSDL at https://www.evoting.nsdl.com/.

The above information is a part of company's filings submitted to BSE.

Jun, 2026

Fabtech Technologies secures contract worth Rs 31.23 crore

The contract is for the critical internal infrastructure scope of a new Veterinary Vaccine Manufacturing Facility in Botswana

Jun, 2026

Fabtech Technologies informs about new order

Fabtech Technologies has informed that the Company has secured an order/contract from Botswana Vaccine Institute. The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are attached as ‘Annexure A’.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Sigachi Industries informs about newspaper publication

Sigachi Industries has informed that the Audited Financial Results (Standalone & Consolidated) of Sigachi Industries for the quarter and year ended March 31, 2026, as approved in the Board Meeting held on May 30, 2026 and public notice to Shareholders regarding 100 days campaign-Saksham Niveshak for updation of their KYC and other relevant details and claim their unpaid/unclaimed dividends, have been published on May 31, 2026 in the following newspapers: 1. Financial Express 2. Nava Telangana

The above information is a part of company’s filings submitted to BSE.

May, 2026

Fabtech Technologies informs about newspaper publication

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fabtech Technologies has informed that they have published Postal Ballot Notice containing the details of remote e-voting and other related information in the following newspapers dated May 30, 2026: 1. Financial Express (English) 2. Loksatta (Marathi- Regional Language). The copy of the above newspaper publication is enclosed and the same is also disseminated on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Fabtech Technologies shines on bagging order worth Rs 65.10 crore

The order is estimated to be executed by November 30, 2026

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,49,048 Crore
2	Divis Laboratories Ltd.	1,77,179 Crore
3	Torrent Pharmaceuticals Ltd.	1,57,804 Crore
4	Apollo Hospitals Enterprise Ltd.	1,25,057 Crore
5	Cipla Ltd.	1,17,642 Crore
6	Dr. Reddys Laboratories Ltd.	1,12,368 Crore
7	Max Healthcare Institute Ltd.	1,09,728 Crore
8	Zydus Lifesciences Ltd.	1,09,691 Crore
9	Lupin Ltd.	1,09,676 Crore
10	Mankind Pharma Ltd.	1,02,729 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,722	54,657	35.22	11.45	24.04	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	72.94	18.81	38.40	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	39.56	9.23	26.73	25.35
Lupin Ltd. (M)	Somewhat Good	2,399	1,09,676	20.57	4.89	11.90	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,09,691	21.76	4.22	13.36	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,525	82,399	101
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	37,225	41.28
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	39.25
Aurobindo Pharma Ltd. (M)	Very Good	1,560	89,762	34.75
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	31.18
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	37,225	55.22	9.22	33.44	15.51
Mankind Pharma Ltd. (M)	Very Good	2,487	1,02,729	50.42	6.27	31.67	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	39.56	9.23	26.73	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,12,368	26.78	2.98	14.95	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	72.94	18.81	38.40	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,09,691	21.76	4.22	13.36	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,872	4,49,048	39.12	5.37	22.41	23.50
Abbott India Ltd. (M)	Very Good	25,722	54,657	35.22	11.45	24.04	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,12,368	26.78	2.98	14.95	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,195	61,943	45.48	5.89	12.07	14.41

You have 6 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Fabtech Technologies informs about outcome of postal ballot

Fabtech Technologies secures contract worth Rs 31.23 crore

Fabtech Technologies informs about new order

Sigachi Industries informs about newspaper publication

Fabtech Technologies informs about newspaper publication

Fabtech Technologies shines on bagging order worth Rs 65.10 crore

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.